AI is Redefining the Hepatitis B and C Diagnostics Market, Set to Grow by USD 3.02 Billion from 2024-2028 with Rising Demand for Molecular Diagnostics - Technavio [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
and c diagnostics market size is estimated to grow by USD 3.02 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.09% during the forecast period. Growing demand for molecular diagnostics in diagnosis of HBV and HCV is driving market growth, with a trend towards advent of immunosensors in HBV and HCV diagnostic tests. However, low penetration of HBV and HCV diagnostic tests poses a challenge. Key market players include Abbott Laboratories, Bio Rad Laboratories Inc., bioMerieux SA, DAAN Gene Co. Ltd., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., MedMira Inc., OraSure Technologies Inc., Perkin Elmer Inc., QIAGEN NV, Quidelortho Corp., Randox Laboratories Ltd., Siemens AG, Sysmex Corp., and Xiamen Innovax Biotech Co. Ltd.. Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View the snapshot of this report Hepatitis B And C Diagnostics Market
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Declares 403rd Consecutive Quarterly DividendPR Newswire
- Abbott a new overweight at Piper Sandler; at attractive entry point [Seeking Alpha]Seeking Alpha
- Jim Cramer: Don't let Abbott Labs' litigation overhang keep you out of the stock [CNBC]CNBC
- Abbott Laboratories (NYSE: ABT) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $131.00 price target on the stock.MarketBeat
- Abbott Laboratories' (NYSE:ABT) Stock Been Rising: Are Strong Financials Guiding The Market? [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- 9/4/24 - Form 4
- ABT's page on the SEC website